A new target in CTCL: Treating the skin, blood, and lymph nodes [interview] Journal Article
| Author: | Horwitz, S. M. |
| Article Title: | A new target in CTCL: Treating the skin, blood, and lymph nodes [interview] |
| Keywords: | cancer chemotherapy; survival rate; overall survival; histone deacetylase inhibitor; interferon; note; progression free survival; quality of life; skin biopsy; skin defect; rash; cutaneous t cell lymphoma; immunotherapy; lymphoma; vorinostat; corticosteroid; disease control; immunosuppressive treatment; ultraviolet b radiation; life expectancy; t cell leukemia; romidepsin; disease exacerbation; mycosis fungoides; retinoid; phase 3 clinical trial (topic); body surface; sezary syndrome; photopheresis; phototherapy; cancer prognosis; brentuximab vedotin; chemokine receptor ccr4; human; mogamulizumab |
| Journal Title: | Clinical Advances in Hematology & Oncology |
| Volume: | 17 |
| Issue: | 1 |
| ISSN: | 1543-0790 |
| Publisher: | Millennium Medical Publishing, Inc |
| Date Published: | 2019-01-01 |
| Start Page: | 40 |
| End Page: | 43 |
| Language: | English |
| PUBMED: | 30843897 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Source: Scopus |
